Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO).
Date on which the share buy-back programme was announced:
30 November 2022.
The duration of the buy-back programme:
20 January 2023 until and including the day before the Company’s Annual General Meeting in 2024.
Size of the buy-back programme:
Up to 666,666 shares, for a maximum consideration of NOK 20,000,000.
From 24 April 2023 until 3 May 2023 CSAM has purchased a total of 7,868 own shares at an average price of 40.1643 per share.
Aggregated overview of transactions per day:
|Date||Aggregate daily volume (# of shares)||Weighted average price (NOK)||Total transaction value (NOK)|
|Previously disclosed buy-backs under the programme (aggregate)||62,949||37.5963||2,366,651.52|
|Total purchased under the programme||70,817||37.8816||2,682,664.43|
This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.
Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached with this report. Download appendix.
For more information, please contact:
Chief Financial Officer
+47 91 55 45 32
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 27 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM has more than 300 dedicated specialists in ten countries across Europe, Asia, Oceania and North America, including a wholly owned software engineering subsidiary in the Philippines.